Relation between impairment in nitric oxide pathway and clinical status in patients with congestive heart failure

Journal of Cardiovascular Pharmacology

Volumn 32, Issue 4, 1998, Pages 562-570

  Carville, Claudine ^a,b   Adnot, Serge ^a   Sediame, Said ^a   Benacerraf, Sophie ^b   Castaigne, Alain ^b   Calvo, Fabien ^a   De Cremou, Patricia ^a   Dubois Rande, Jean Luc ^b  

^a SAINT LOUIS HOSPITAL   (France)

^b HENRI MONDOR HOSPITAL   (France)

Author keywords

Endothelium; Forearm blood flow; Heart failure; Nitric oxide

Indexed keywords

ACETYLCHOLINE; ARGININE DERIVATIVE; CYTOKINE; NITRATE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; NITROPRUSSIDE SODIUM; NORADRENALIN;

ADULT; AGED; ARTICLE; BLOOD VESSEL REACTIVITY; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; FOREARM BLOOD FLOW; HEART LEFT VENTRICLE EJECTION FRACTION; HOMEOSTASIS; HUMAN; MALE; PATHOPHYSIOLOGY; PRESSOR RESPONSE; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE; VASOCONSTRICTION;

ACETYLCHOLINE; ENZYME INHIBITORS; FEMALE; FOREARM; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; NITRATES; NITRIC OXIDE; NITRITES; NITROPRUSSIDE; OMEGA-N-METHYLARGININE; PLETHYSMOGRAPHY; SEVERITY OF ILLNESS INDEX; VASODILATION; VASODILATOR AGENTS;

EID: 0031706640     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199810000-00008     Document Type: Article

References (25)

1. Katz SD, Biasucci L, Sabba C, et al. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol 1992;19:918-25.
2. Drexler H, Hayoz D, Münzel T, et al. Endothelial function in chronic congestive heart failure. Am J Cardiol 1992;69:1596-601.
3. Lücher TF, Noll G. Endothelium-dependent vasomotion in aging, hypertension, and heart failure. Circulation 1993;87:VII97-A03.
4. Kaiser L, Spickard RC, Olivier BC. Heart failure depresses endothelium-dependent response in canine femoral artery. Am J Physiol 1989;256:H962-7.
5. Ontkean M, Gay R, Greenberg B. Diminished endothelium-derived relaxing factor activity in an experimental model of chronic heart failure. Circ Res 1991;69:1088-96.
6. Levy B, Valladeres WR, Ghaem A, Martineaud JP. Comparison of plethysmographic methods with pulsed Doppler blood flowmetry. Am J Physiol 1979;236(6):H899-903.
7. Green L, Ruiz De Luzuriaga K, Wagner D. Nitrate biosynthesis in man. Proc Natl Acad Sci U S A 1981;78:7764-8.
8. Katz SS, Rao R, Berman JW, et al. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Circulation 1994;90:12-6.
9. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Enql J Med 1990;323:236-41.
10. Kubo SH, Rector TS, Bank AJ, et al. Lack of contribution of nitric oxide to basal vasomotor tone in heart failure. Am J Cardiol 1994;74:1133-6.
11. Motoyuki N, Motoko I, Tsutomu F, Kohya H, Makoto C, Katsuhiko H. Attenuated endothelium-dependem peripheral vasodilation and clinical characteristics in patients with chronic heart failure. Am Heart J 1994;128:1164-9.
12. Campillo B, Chabrier P, Pelle G, et al. Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis. Hepatology 1995;22:1423-9.
13. Habib F, Dutka D, Crossman D, Oakley CM, Cleland JF. Enhanced basal nitric oxide production in heart failure: another failed counter-regulatory vasodilator mechanism? Lancet 1994;344:371-3.
14. Winslaw DS, Smythe GA, Keogh AM, Schyvens CG, Spratt PM, MacDonald PS. Increased nitric oxide production in heart failure. Lancet 1994;344:373-4.
15. Ros J, Jimenez W, Lamas S, Claria J, Arroyo V, Rivera F. Nitric oxide production in arterials vessels of cirrhotic rats. Hepatology 1995;21:554-60.
16. Rees D, Cellek S, Palmer R, Moncada S. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem Biaphys Res Commun 1990;173:541-7.
17. Moncada S. The L-arginine nitric oxide pathway. Acta Physiol Scand 1992;145:201-7.
18. Piczueta P, Pique J, Fernandez M, et al. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition. Gastroenterology 1992;103:1915-9.
19. Vallance P, Moncada S. Hyperdynamic circulation in cirrhosis, a role for nitric oxide? Lancet 1991;337:776-9.
20. de Belder AS, Radomski MW, Why HS. Nitric oxide synthase activities in human myocardium. Lancet 1993;341:84-5.
21. Hirooka Y, Imaizumi T, Harada S, et al. Endothelium-dependent forearm vasodilation with acetylcholine but not that with substance P is impaired in patients with heart failure. J Cardiovasc Pharmacol 1992;20(suppl 12):S221-5.
22. Augus J, Lew M. Interpretation of the acetylcholine test of endothelial cell dysfunction. Hypertension 1992;10:S179-86.
23. Eglen R, Whiting R. Determination of the muscarinique receptor subtype mediating vasodilation. Br J Pharmacol 1985;84:4-5.
24. Hayoz D, Drexler H, Munzel T, et al. Flow mediated arterial dilation is abnormal in congestive heart failure. Circulation 1993;87:VII-92-6.
25. Gilligan D, Panza J, Kilcoyne C, Waclawiw M, Casino P, Quyyumi A. The contribution of endothelium-derived nitric oxide to exercise-induced vasodilation. Circulation 1994;90:2853-8.